KindlyMD announces $5B at-the-market equity offering program

Kindly MD announced that it has filed a shelf registration statement and prospectus supplement with the U.S. SEC establishing an at-the-market equity offering program under which it may issue and sell shares of its common stock having an aggregate offering price of up to $5B. Pursuant to the terms of the sales agreement, dated August 26, 2025, among KindlyMD (NAKA) and TD Securities; Cantor; B. Riley Securities, Inc; Benchmark, a StoneX Company; Canaccord Genuity; Cohen & Company Capital Markets; Craig-Hallum; Needham & Company; and Yorkville Securities, sales of the Offered Shares, if any, of the NAKA Stock under the ATM Program will be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, including sales made directly on or through the Nasdaq Global Market or any other existing trading market for the NAKA Stock.